Summit Therapeutics plc Summit Therapeutics Plc : Change Of Registered Office
31 March 2017 - 12:00AM
UK Regulatory
TIDMSUMM
Summit Therapeutics plc
('Summit', 'the Company')
SUMMIT ANNOUNCES CHANGE OF REGISTERED COMPANY ADDRESS
Oxford, UK, 30 March 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ:
SMMT), the drug discovery and development company advancing therapies
for Duchenne muscular dystrophy and Clostridium difficile infection,
announces that the registered office address of the Company has changed
to 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire, OX14 4SB, UK
with immediate effect.
All other details remain the same including the Company's website
(www.summitplc.com), telephone number (+44 (0) 1235 443 939) and fax
number (+44 (0) 1235 443 999).
This announcement has been made in accordance with Rule 17 of the AIM
Rules for Companies.
About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery,
development and commercialisation of novel medicines for indications for
which there are no existing or only inadequate therapies. Summit is
conducting clinical programs focused on the genetic disease Duchenne
muscular dystrophy and the infectious disease C. difficile infection.
Further information is available at www.summitplc.com and Summit can be
followed on Twitter (@summitplc).
For more information, please contact:
Summit
Glyn Edwards / Richard Pye (UK office) Tel: +44 (0)1235 443 951
Erik Ostrowski / Michelle Avery (US office) +1 617 225 4455
Cairn Financial Advisers LLP
(Nominated Adviser) Tel: +44 (0)20 7213 0880
Liam Murray / Tony Rawlinson
-END-
This announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: Summit Therapeutics plc via Globenewswire
http://www.summitplc.com/
(END) Dow Jones Newswires
March 30, 2017 09:00 ET (13:00 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Summit Therapeutics (LSE:SUMM)
Historical Stock Chart
From Apr 2024 to May 2024
Summit Therapeutics (LSE:SUMM)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Summit Therapeutics Plc (London Stock Exchange): 0 recent articles
More Summit Ther News Articles